Multiple beneficial actions of fructose 1,6-biphosphate in sepsis-associated liver injury

Critical Care Medicine

Volumn 34, Issue 3, 2006, Pages 927-929

  Muntané, Jordi ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Cell death; Glycolysis; Hepatocytes; Kupffer cells; Mast cells

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOKINE; FRUCTOSE 1,6 BISPHOSPHATE; GALACTOSAMINE; GLYCOGEN; URIDINE DIPHOSPHATE GLUCOSE;

DISEASE ASSOCIATION; DRUG MECHANISM; EDITORIAL; GLYCOLYSIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LIVER CELL; LIVER INJURY; LIVER TOXICITY; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; POTASSIUM TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS;

ANIMALS; BIOLOGICAL RESPONSE MODIFIERS; FRUCTOSEDIPHOSPHATES; HEPATOCYTES; KUPFFER CELLS; LIVER FAILURE, ACUTE; MACROPHAGE ACTIVATION; POTASSIUM CHANNELS; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33644588868     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000202436.45295.6E     Document Type: Editorial

References (16)

1. Williams R, Gimson AES: Intensive liver care and management of acute hepatic failure. Dig Dis Sci 1991; 36:820-826
2. Rolando N, Harvey F, Brahm J, et al: Prospective study of bacterial infection in acute liver failure: An analysis of fifty patients. Hepatology 1990; 11:49-53
3. Kaplowitz N: Biochemical and cellular mechanisms of toxic liver injury. Semin Liver Dis 2002; 22:137-144
4. Isselbacher KJ, Jones WA: Alterations of glucose metabolism in viral and toxic liver injury. Gastroenterology 1964; 46:424-433
5. Cuesta E, Boada J, Calafell R, et al: Fructose 1,6-bisphosphate prevented endotoxemia, macrophage activation, and liver injury induced by D-galactosamine in rats. Crit Care Med 2006; 34:807-814
6. Decker K, Keppler K: Studies on the mechanism of galactosamine hepatitis: Accumulation of galactosamine-1-phosphate and its inhibition of UDP-glucose pyrophosphorylase. Eur J Biochem 1969; 10:219-225
7. Liehr H, Grun M, Seeling H: On the pathogenesis of galactosamine hepatitis. Virchows Arch B Cell Pathol 1978; 26:331-335
8. De Oliveira JR, Rosa JL, Ambrosio S, et al: Effect of galactosamine on hepatic carbohydrate metabolism: Protective role of fructose 1,6 bisphosphate. Hepatology 1992; 15:1147-1153
9. 4 hepatotoxicity in rats. Biochem J 1989; 262:721-725
10. Bordignon Nunes F, Guerra Simoes Pires M, Farias Alves JC, et al: Physiopathological studies in septic rats and the use of fructose 1,6-biphosphate as cellular protection. Crit Care Med 2002; 30:2069-2074
11. Markov AK, Oglethorpe N, Blade TM, et al: Hemodynamic, electrocardiographic, and metabolic effects of fructose diphosphate on acute myocardial ischemia. Am Heart J 1980; 100:639-646
12. Markov AK, Turner MD, Oglethorpe NC, et al: Fructose-1,6 diphosphate: An agent for treatment of experimental endotoxin shock. Surgery 1981; 90:482-488
13. Roig T, Bartrons R, Bermudez J: Exogenous fructose 1,6-biphosphate reduces K+ permeability in isolated rat hepatocytes. Am J Physiol 1997; 273:C473-C478
14. Frenzel J, Richter J, Eschrich K: Fructose inhibits apoptosis induced by reoxygenation in rat hepatocytes by decreasing reactive oxygen species via stabilization of the glutathione pool. Biochim Biophys Acta 2002; 1542:82-94
15. Seydel U, Scheel O, Muller M, et al: A K+ channel is involved in LPS signaling. J Endotoxin Res 2001; 7:243-247
16. Stachlewitz RF, Seabra V, Bradford B, et al: Glycine and uridine prevent D-galactosamine hepatotoxicity in the rat: Role of Kupffer cells. Hepatology 1999; 29:737-745